A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
What is the purpose of this trial?
To evaluate the effect of Cobicistat containing regimens on renal parameters.
- 18 Years and older
- Gilead Sciences
- February 2012
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale4313884